[Small-cell lung cancer and subacute sensory neuropathy in a patient positive for the anti-Hu antigen]

Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Jul;34(7):816-21.
[Article in Japanese]

Abstract

We encountered a case of small-cell lung cancer in a patient with subacute sensory neuropathy that began 5 months before the cancer was diagnosed. A 60-year-old man complained of abnormalities in the functioning of his peripheral sensory systems (senses of pain, touch, position, and vibration). A chest X-ray film obtained on admission showed an anterior mediastinal tumor. The anti-Hu antibody was found in his serum. The diagnosis was small-cell lung cancer. Combination chemotherapy (cisplatin and irinotecan, CPT-11) was begun and the response was a complete remission. The symptoms of neuropathy continued. The anti-Hu antibody was useful in the diagnosis in the case of small-cell lung cancer combined with subacute sensory neuropathy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antibodies, Anti-Idiotypic / analysis*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Autoantibodies / analysis*
  • Biomarkers, Tumor / analysis*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Carcinoma, Small Cell / complications*
  • Carcinoma, Small Cell / diagnosis*
  • Carcinoma, Small Cell / drug therapy
  • Cisplatin / administration & dosage
  • Humans
  • Irinotecan
  • Lung Neoplasms / complications*
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases / etiology*

Substances

  • Antibodies, Anti-Idiotypic
  • Autoantibodies
  • Biomarkers, Tumor
  • Irinotecan
  • Cisplatin
  • Camptothecin